Virogates boss excited about IPO: Will speed up sale of blood test

The diagnostics company Virogates wants to bring in more than DKK 60 million (USD 9.4 million) on the stock exchange, which will be used to boost sales of the company's blood test. The goal is to have 40 paying customers in two years says CEO.

Jakob Knudsen, CEO of Virogates. Photo: Virogates

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles